The development of a novel oral 5-Fluorouracil in-situ gelling nanosuspension to potentiate the anticancer activity against colorectal cancer cells
- 1 February 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 613, 121406
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Chitosan nanoparticles: a survey of preparation methodsJournal of Drug Targeting, 2012
- Alginate–antacid combinations: raft formation and gastric retention studiesDrug Development and Industrial Pharmacy, 2009
- 5-Fluorouracil: Mechanisms of Resistance and Reversal StrategiesMolecules, 2008
- Characterization of calcium alginate beads of 5-fluorouracil for colon deliveryAsian Journal of Pharmaceutics, 2008
- Preparation of Calcium Alginate Microgel Beads in an Electrodispersion Reactor Using an Internal Source of Calcium Carbonate NanoparticlesLangmuir, 2007
- Stomach-specific drug delivery of 5-fluorouracil using floating alginate beadsAAPS PharmSciTech, 2007
- Alginate rafts and their characterisationInternational Journal of Pharmaceutics, 2005
- 5-Fluorouracil encapsulated alginate beads for the treatment of breast cancerInternational Journal of Pharmaceutics, 2002
- Evaluation of alginate compressed matrices as prolonged drug delivery systemsAAPS PharmSciTech, 2000
- An Investigation into Eventual Interactions between Clenbuterol and Some Mucolytic Drugs by Differential Scanning CalorimetryDrug Development and Industrial Pharmacy, 1988